当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › In Vivo杂志
In Vivo
基本信息
期刊名称 In Vivo
IN VIVO
期刊ISSN 0258-851X
期刊官方网站 http://iv.iiarjournals.org/
是否OA No
出版商 International Institute of Anticancer Research
出版周期 Bimonthly
文章处理费 登录后查看
始发年份
年文章数 356
影响因子 1.8(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 4.2 0.555 0.679
Biochemistry, Genetics and Molecular Biology
General Biochemistry, Genetics and Molecular Biology
91/221 59%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
169/313 46%
Biochemistry, Genetics and Molecular Biology
Cancer Research
147/230 36%
补充信息
自引率 5.6%
H-index 54
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0258-851X%5BISSN%5D
投稿指南
期刊投稿网址 http://iv.iiarjournals.org/site/misc/submissions.xhtml
收稿范围
IN VIVO (IV) is a multidisciplinary journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis; 10. Retrospective studies and case reports. Each article should include a concrete conclusion constituting of a “new piece of knowledge” backed up by unambiguous and accurate scientific evidence. The principal aim of IN VIVO is to provide prompt online publication for accepted articles, generally within 1-2 months from final acceptance.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug